Xiaojing Li

Tanshinone IIA Has a Potential Therapeutic Effect on Kawasaki Disease and Suppresses Megakaryocytes in Rabbits With Immune Vasculitis

Xiao-Yong Zhan, Wenfang Yi, Liang Li, 2022, Frontiers in Cardiovascular Medicine.

Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low‐dose secondary prophylaxis study

V. Blanchette, A. Abad, Zhenping Chen, 2021, Research and practice in thrombosis and haemostasis.

The Efficacy of Recombinant FVIII Low-Dose Prophylaxis in Chinese Pediatric Patients With Severe Hemophilia A: A Retrospective Analysis From the ReCARE Study

J. Gu, G. Feng, Juan Xiao, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO‐KLAT

V. Blanchette, N. Young, R. Wu, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Status and trend analysis of prophylactic usage of recombinant factor VIII in Chinese pediatric patients with hemophilia A: ReCare – a retrospective, phase IV, non-interventional study

J. Gu, R. Wu, Yongqiang Zhao, 2017, Current medical research and opinion.

Pharmacokinetics and complementary evaluation system-based guidance on prophylaxis of paediatric patients with haemophilia A in China with Kovaltry: protocol of the LEAP study

Zhenping Chen, R. Wu, Zhongjin Xu, 2021, BMJ Open.

Long-term efficacy and safety of prophylaxis with recombinant factor VIII in Chinese pediatric patients with hemophilia A: a multi-center, retrospective, non-interventional, phase IV (ReCARE) study

J. Gu, R. Wu, Yongqiang Zhao, 2017, Current medical research and opinion.

Cross-cultural adaptation of the CHO-KLAT for boys with hemophilia in rural and urban china

Jishui Zhang, V. Blanchette, N. Young, 2012, Health and Quality of Life Outcomes.